BTG Trademark Information

BTG INTERNATIONAL LIMITED

Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, liquid medical seal...

Computer hardware for medical imaging apparatus; computer firmware for controlling medical devices; computer firmware for controlling and managing patient medical information; computer hardware; computer peripherals; computer software and computer programs for medical monitoring, medical testing and patient evaluating programs; computer programs for controlling and managing patient medical information; computer software for use in medical devi...

Surgical, medical, dental and veterinary apparatus and instruments, namely, cryoablation needles, medical syringes, electrically powered tissue ablation devices, surgical and medical apparatus and instruments for producing and administering pharmaceutical foams, surgical and medical apparatus and instruments for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles, devices for intrav...

Education, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments, pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory s...

This is a brand page for the BTG trademark by BTG INTERNATIONAL LIMITED  in London, , EC4M7RD.

Write a review about a product or service associated with this BTG trademark. Or, contact the owner BTG INTERNATIONAL LIMITED of the BTG trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the BTG trademark.

Status Update! On Wednesday, September 13, 2017, status on the BTG trademark changed to NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED.

On Thursday, March 31, 2016, a U.S. federal trademark registration was filed for BTG by BTG INTERNATIONAL LIMITED, London EC4M7RD. The USPTO has given the BTG trademark serial number of 86960150. The current federal status of this trademark filing is NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED. The correspondent listed for BTG is JONATHAN A. HYMAN of KNOBBE MARTENS OLSON & BEAR, LLP, 2040 MAIN STREET, 14TH FLOOR, IRVINE, CA 92614 . The BTG trademark is filed in the category of Pharmaceutical Products , Computer & Software Products & Electrical & Scientific Products , Medical Instrument Products , Education and Entertainment Services . The description provided to the USPTO for BTG is Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; sanitary preparations for medical purposes; vaccines; pharmaceutical and medicinal preparations and substances, namely, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; diagnostic reagents and substances, all for in vivo medical use; antibodies, and therapeutic antibodies for use as anti-lymphocytic agents for medical use; pharmaceutical preparations in the form of foams or for use in producing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of cancer, circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, intracranial hemorrhages, cerebral hemorrhages, hematomas, and as antidotes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders namely, type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical prepraations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical or veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumours; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and/or medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and treatment of autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents.

Word mark: BTG
Status/Status Date:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
9/13/2017
Estimated Response Deadline: 3/13/2018
Serial Number: 86960150
Filing Date: 3/31/2016
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; sanitary preparations for medical purposes; vaccines; pharmaceutical and medicinal preparations and substances, namely, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; diagnostic reagents and substances, all for in vivo medical use; antibodies, and therapeutic antibodies for use as anti-lymphocytic agents for medical use; pharmaceutical preparations in the form of foams or for use in producing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of cancer, circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, intracranial hemorrhages, cerebral hemorrhages, hematomas, and as antidotes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders namely, type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical prepraations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical or veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumours; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and/or medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and treatment of autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents
Mark Description: The mark consists of a shaded circle with four diagonal narrowing notches inside of it; below the circle are the letters "BTG" in stylized lettering.
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner: BTG INTERNATIONAL LIMITED
London EC4M7RD
Mark Drawing Code: Drawing/Design + Words
Design Search:
Circles that are totally or partially shaded. (Geometric figures and solids - Coding and searching guide) see more design...
Diagonal line(s), band(s) or bar(s) (Geometric figures and solids - Lines, bands, bars, chevrons and angles) see more design...
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
KNOBBE MARTENS OLSON & BEAR, LLP
2040 MAIN STREET, 14TH FLOOR
IRVINE, CA 92614

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Classification Information

Primary Class: Class (005) - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: Not provided
First Use In Commerce: Not provided
Primary Class: Class (009) - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
First Use Anywhere: Not provided
First Use In Commerce: Not provided
Primary Class: Class (010) - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
First Use Anywhere: Not provided
First Use In Commerce: Not provided
Primary Class: Class (041) - Education; providing of training; entertainment; sporting and cultural activities.
First Use Anywhere: Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 170+ countries in the world through LegalForce Network.

LegalForce Network can help you incorporate a business around your BTG trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Legalforce RAPC - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global IP Attorneys - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Keep Track of this Brand.

Trademark Watch Services

Keep track of how your trademark is being used. Available in the United States and in more than 176 countries. Round-the-clock monitoring. Monthly report on potential infringement.

Trademark Watch Services read more...
Current Trademark Status:
9/13/2017
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
Free Trademark Search:
Correspondent Search:

JONATHAN A. HYMAN is a correspondent of BTG trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!